CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 2,900 shares (option exercise)
- 4 Open-market buy 10% owner bought 100,000 shares at $11.60 ($1,160,000)
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 13,100 shares (option exercise)
- 3/A Insider 3/A
- 4 Planned sale Director sold 25,000 shares at $12.57 ($314,250)
- 4 Open-market sale Director sold 8,181 shares at an average $14.39 ($117,740)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 14,556 shares at an average $14.38 ($209,296)
- 4 Open-market sale CH. DISCOV. & NON-CLIN DEV OFF sold 13,629 shares at an average $14.40 ($196,233)
- 4 Open-market sale PRESIDENT AND CEO sold 57,225 shares at an average $14.40 ($824,134)
- 4 Open-market sale CH. OPERATING & FINANCIAL OFF. sold 18,742 shares at an average $14.39 ($269,656)
- 4 Planned sale CH. DISCOV. & NON-CLIN DEV OFF sold 200 shares at $17.61 ($3,522)
- 4 Planned sale CH. DISCOV. & NON-CLIN DEV OFF sold 10,541 shares at an average $15.26 ($160,806)
- 4 Planned sale Director sold 30,000 shares at an average $12.65 ($379,450)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 25,000 shares at $12.41 ($310,250)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CH. DISCOV. & NON-CLIN DEV OFF sold 20,000 shares at $12.67 ($253,400)
- 4 Open-market buy Director bought 1,505,932 shares at $9.84 ($14,818,371)
- 4 Planned sale Director sold 25,000 shares at an average $10.26 ($256,600)
Page 6 of 13 · 244 filings